All Harm, No Help in 340B Cuts
Now that a U.S. District Court has postponed the hospital industry’s legal challenge to cutbacks in the 340B drug discount program, it falls to Congress to reverse the Trump administration’s egregious new rules. Believe it or not, there’s hope, since the new rules benefit no one—quite literally. Legislation reversing them has even gained bipartisan backing…